Key statistics
On Thursday, Adicet Bio Inc (0HX7:LSE) closed at 1.56, 46.58% above the 52 week low of 1.07 set on Jul 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 1.56 |
Low | 1.56 |
Bid | -- |
Offer | -- |
Previous close | 1.56 |
Average volume | 2.07k |
---|---|
Shares outstanding | 82.40m |
Free float | 81.09m |
P/E (TTM) | -- |
Market cap | 126.07m USD |
EPS (TTM) | -2.53 USD |
Data delayed at least 20 minutes, as of Sep 19 2024 16:47 BST.
More ▼
Press releases
- ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue
- Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors
- Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates
- Adicet Bio to Participate in Upcoming Investor Conferences
- Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
- Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
More ▼